SCIE gearing up for Barrett's technology.. Go

New Post Public Reply Private Reply Replies (0) Message Board
joey68
SCIE gearing up for Barrett's technology..

Go here:
https://clinicaltrials.gov/show/NCT00747136

Quote:
This study has suspended participant recruitment.


OH NO! The study was SUSPENDED!! Its the end of the world as we know it!! SCIE is closing their doors! The font color is red too?? WHY IS IT RED! ISNT RED 'BAD'??? BAHHHHH!

..actually, calm down and read on....

Quote:
(Study has been suspended while company continues to develop the technology)


Ahhh! So the study wasn't actually 'canceled' . Instead, the trial was received in 2008 and suspended because the men and women behind Spectra Science realized they needed to improve their technology before continuing on with the trial.

How do I know this? Because it says, "company continues to develop the technology". They discovered at some point during the trial their technology wasn't sufficient enough, so they had to 'DEVELOP' it.

So what does this mean? I HAVE NO CLUE! Just kidding . Keep reading..
Scroll down the page and look at the key words to this trial:
Quote:
Keywords provided by SpectraScience:
Barrett's
Dysplasia
Esophageal cancer
Patients


BARRETTS? Spectra Science sells hair clips for women??
NOO YOU GOOFBALL!.
Remember the recent acquisition with Oncoscope?
https://www.pehub.com/2016/02/spectrascience-...oncoscope/

Quote:
Michael Oliver.. went on to say, “Oncoscope’s focus on a diagnostic for Barrett’s Esophagus will shorten the development time for a commercial product to address this indication. With a solution for diagnosis of cancer in the upper GI as well as the lower GI, we will be able to more efficiently utilize our manufacturing capabilities and leverage the sales channel to Gastroenterologists.”


See where this is going? Back in 2008 to 2011, Spectra Science was investigating the WavSTAT4's capabilities to detect cancer in the throat (Barrett's), but the technology they wanted either didn't exist at the time, or they didn't have the money to create it themselves.

So what did they do about it?

Instead of pouting and crying over the fact that their WavSTAT didn't have the capabilities at the time to properly detect Barrett’s Esophagus, they put the study on the backburner and continued to develop the WavSTAT4 model to better detect colorectal cancer.

I bet, once this acquisition with Oncoscope is complete, and they integrate the technology into the WavSTAT4, SCIE will initiate a new investigation trial for Barrett's.

Or better yet, behind closed doors, Spectra Science has another product we don't even know about!

Right now, you might be saying, "Oh come on Joey68, this time you've gone TOO FAR! SCIE does NOT have another product besides the WavSTAT4. Joey68, you've done one too many DD posts. You cray-cray!"

Well, go here:
http://www.biotechgate.com/biocom/db/detail.p...UbUzzq4tv6

Quote:
No. of Medtech Products:
In development: 2
On the market :1


That does say two products in development, right? How many products do we know about? We know of the WavSTAT4 and.....? It also says 'On the market:1'. That has to be the WavSTAT4 because its showing up on the PENTAX Germany/Spain/UK site as available.

We know SCIE just acquired Oncoscope. Why is it automatically assumed Oncoscope technology will be crammed into the WavSTAT4? Wouldn't it make more sense to create a totally separate device for Barrett's Esophagus? Time will tell.

And so, this trial back in 2008-2011 was canceled because they needed to find the right technology. In the meantime, they continued their research, trials, and improvements on the WavSTAT4. Eventually, someone at SCIE had a conversation like this:

"Hey Michael Oliver, remember that trial for Barrett's we suspended years ago because we didn't have the technology?
"Yes."
"You know how we've been trying to get our hands on the technology?"
"Yes."
"I found out Oncoscope has the tech and theyre going out of business. Let's buy their tech and incorporate it into our portfolio. Once we do that, we can start that trial back up, get the results, and market it."
"Sounds good, lets do it."

Hence... the Oncoscope acquisition. Which means, all this time, despite nay-sayers trying to tell us Spectra Science management has been doing nothing for the past 5 years, in reality, they've been actively investigating ways to enhance their product. Let the games begin.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 6

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 8

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 6

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Update: Futures Rise as Key Stocks Gain Momentum

Updated Category News Views 109

Market Overview U.S. stock futures have shown an upward trend following a positive closing on the previous trading day. Major benchmark indices are seeing gains, leading investors to keep a close eye on market movements as the holiday season approaches. Index Performance In the week prior, the S&P 500 faced a slight decline of 0.37%, with other indices like the Nasdaq...

Continue Reading
Faye Celebrates Recognition Among Fastest-Growing Companies

Updated Category News Views 248

Faye's Remarkable Achievement in Business Growth Faye, a distinguished leader in the field of software strategy, deployment, and management, has reached an exciting milestone. The company has earned a spot on the prestigious 2025 Inc. Regionals: Pacific list, which honors the fastest-growing private companies in the Pacific region. This recognition not only showcases...

Continue Reading
Shinjiro Koizumi's Vision for Change and Future Diplomacy

Updated Category News Views 322

Shinjiro Koizumi's Game-Changer Status in Japanese Politics At a pivotal moment for Japan’s political scene, Shinjiro Koizumi is stepping into the spotlight. This guy isn’t your usual politicos’ fare—he’s young, energetic, and poised to bring a fresh vibe to a landscape crowded with seasoned players like Shigeru Ishiba and Sanae Takaichi. If you’re looking for...

Continue Reading
Doman Building Materials Expands Offerings with New Notes

Updated Category News Views 188

Doman Building Materials Group Ltd. Enhances Financial Strategy Doman Building Materials Group Ltd. (“Doman” or the “Company”) (TSX: DBM) has successfully completed a private placement offering, raising $170 million through the sale of senior unsecured notes. This notable move marks an important step in the Company’s ongoing strategy to optimize its financial...

Continue Reading
Enhancing Your Home's Air Quality: Tips for Healthier Living

Updated Category News Views 46

Enhancing Your Home's Air Quality Petri Plumbing, Heating, Cooling & Drain Cleaning emphasizes that homeowners can celebrate National Indoor Air Quality Month by implementing straightforward strategies to improve their indoor air conditions. Acknowledge the Problem "In October, we're supposed to be scared of ghosts and goblins but not of our indoor air," remarked Michael...

Continue Reading